InvestorsHub Logo
Followers 231
Posts 38580
Boards Moderated 0
Alias Born 03/12/2015

Re: 02opida post# 169229

Saturday, 08/01/2020 11:38:17 AM

Saturday, August 01, 2020 11:38:17 AM

Post# of 186029
$VRUS Price to Revenue Ratio (P/R) is at 0.40 based on 12 trailing months (TTM) revenue of 19 million dollars. Q3 is expected to generate over 8 million dollars of revenue. If we include Q3 in the 12 TTM revenue analysis, the total TTM revenue would be 23.6 million dollars with a P/R of 0.33....VRUS is highly undervalued with very low debt. It is a great time to add shares here if you are new or long on VRUS. News next week where VRUS will show a great progress with Pachyderm Labs and BLF, as shown Here and Here


  • Q3, 2020: 8 mil, predicted, Ending July 31, Due on Monday, September 14
  • Q2. 2020: 4.65 mil, COVID-19 hardest quarter, Ending April 30
  • Q1, 2020: 6.2 mil, Ending January 31
  • Q4, 2019: 4.7 mil, Ending October 31
  • Q3, 2019: 3.5 mil, Ending July 31
  •